Background: We present a case of a 42-year female with Tumor induced osteomalacia (TIO) who presented with multiple fragility fractures and decrease in height. The duration from symptom onset to the diagnosis and treatment was 5 years. It is imperative to keep TIO as differential in patients with chronic hypophosphatemia and osteomalacia.
No takes yet. Share an insight, caveat, or question.
Wasti et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: